CF102 for the treatment of hepatocellular carcinoma: a phase I/II, open-label, dose-escalation study (Q36565624)
Jump to navigation
Jump to search
scientific article published on 8 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CF102 for the treatment of hepatocellular carcinoma: a phase I/II, open-label, dose-escalation study |
scientific article published on 8 January 2013 |
Statements
1 reference
CF102 for the treatment of hepatocellular carcinoma: a phase I/II, open-label, dose-escalation study (English)
1 reference
Pnina Fishman
1 reference
Salomon M Stemmer
1 reference
Ofer Benjaminov
1 reference
Gal Medalia
1 reference
Noab B Ciuraru
1 reference
Michael H Silverman
1 reference
Sara Bar-Yehuda
1 reference
Sari Fishman
1 reference
Zivit Harpaz
1 reference
Motti Farbstein
1 reference
Shira Cohen
1 reference
Renana Patoka
1 reference
Barak Singer
1 reference
William D Kerns
1 reference
Identifiers
1 reference